142 related articles for article (PubMed ID: 33078101)
1. Effect on rabbits' intraocular structure by cross-linked hyaluronic formations as vitreous substitute.
Gong Y; Chen K; Wu Y; Guo XH; Zhang T
Int J Ophthalmol; 2020; 13(10):1531-1537. PubMed ID: 33078101
[TBL] [Abstract][Full Text] [Related]
2. Injectable in situ cross-linking hyaluronan hydrogel for easier removal of posterior vitreous cortex in vitrectomy.
Hisatomi T; Tachibana T; Mori K; Ishikawa K; Ishibashi T; Sonoda KH; Uchio E; Watanabe I; Suzuki K; Iida M
Jpn J Ophthalmol; 2024 Mar; 68(2):146-156. PubMed ID: 38311687
[TBL] [Abstract][Full Text] [Related]
3. The cross-linked biopolymer hyaluronic acid as an artificial vitreous substitute.
Schramm C; Spitzer MS; Henke-Fahle S; Steinmetz G; Januschowski K; Heiduschka P; Geis-Gerstorfer J; Biedermann T; Bartz-Schmidt KU; Szurman P
Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):613-21. PubMed ID: 22199245
[TBL] [Abstract][Full Text] [Related]
4. A cross-linked hyaluronic acid hydrogel (Healaflow(®)) as a novel vitreous substitute.
Barth H; Crafoord S; Andréasson S; Ghosh F
Graefes Arch Clin Exp Ophthalmol; 2016 Apr; 254(4):697-703. PubMed ID: 26743755
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Biocompatibility of a Highly Viscously Thiol-Modified Cross-Linked Hyaluronate as a Novel Vitreous Body Substitute.
Hurst J; Rickmann A; Heider N; Hohenadl C; Reither C; Schatz A; Schnichels S; Januschowski K; Spitzer MS
Front Pharmacol; 2022; 13():817353. PubMed ID: 35308238
[No Abstract] [Full Text] [Related]
6. Injectable self-crosslinking hydrogels based on hyaluronic acid as vitreous substitutes.
Yu S; Wang S; Xia L; Hu H; Zou M; Jiang Z; Chi J; Zhang Y; Li H; Yang C; Liu W; Han B
Int J Biol Macromol; 2022 May; 208():159-171. PubMed ID: 35301003
[TBL] [Abstract][Full Text] [Related]
7. Feasibility study of chitosan as intravitreous tamponade material.
Yang H; Wang R; Gu Q; Zhang X
Graefes Arch Clin Exp Ophthalmol; 2008 Aug; 246(8):1097-105. PubMed ID: 18431591
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory responses after vitrectomy with vitreous substitutes in a rabbit model.
Barth H; Crafoord S; Arnér K; Ghosh F
Graefes Arch Clin Exp Ophthalmol; 2019 Apr; 257(4):769-783. PubMed ID: 30656473
[TBL] [Abstract][Full Text] [Related]
9. An injectable oxidated hyaluronic acid/adipic acid dihydrazide hydrogel as a vitreous substitute.
Su WY; Chen KH; Chen YC; Lee YH; Tseng CL; Lin FH
J Biomater Sci Polym Ed; 2011; 22(13):1777-97. PubMed ID: 20843434
[TBL] [Abstract][Full Text] [Related]
10. Biocompatibility and retinal support of a foldable capsular vitreous body injected with saline or silicone oil implanted in rabbit eyes.
Wang P; Gao Q; Jiang Z; Lin J; Liu Y; Chen J; Zhou L; Li H; Yang Q; Wang T
Clin Exp Ophthalmol; 2012; 40(1):e67-75. PubMed ID: 21883770
[TBL] [Abstract][Full Text] [Related]
11. Ocular biocompatibility of carbodiimide cross-linked hyaluronic acid hydrogels for cell sheet delivery carriers.
Lai JY; Ma DH; Cheng HY; Sun CC; Huang SJ; Li YT; Hsiue GH
J Biomater Sci Polym Ed; 2010; 21(3):359-76. PubMed ID: 20178691
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of two different thiol-modified crosslinked hyaluronate formulations as vitreous replacement compared to silicone oil in a model of retinal detachment.
Schnichels S; Schneider N; Hohenadl C; Hurst J; Schatz A; Januschowski K; Spitzer MS
PLoS One; 2017; 12(3):e0172895. PubMed ID: 28248989
[TBL] [Abstract][Full Text] [Related]
13. A self-healing and injectable hydrogel based on water-soluble chitosan and hyaluronic acid for vitreous substitute.
Wang S; Chi J; Jiang Z; Hu H; Yang C; Liu W; Han B
Carbohydr Polym; 2021 Mar; 256():117519. PubMed ID: 33483040
[TBL] [Abstract][Full Text] [Related]
14. Experiment of vitreous liquefaction induced by C3F8.
Wang J; Li Q
Pak J Pharm Sci; 2017 Jan; 30(1 Suppl):281-287. PubMed ID: 28625955
[TBL] [Abstract][Full Text] [Related]
15. An evaluation of methylated collagen as a substitute for vitreous and aqueous humor.
Liang C; Peyman GA; Serracarbassa P; Calixto N; Chow AA; Rao P
Int Ophthalmol; 1998; 22(1):13-8. PubMed ID: 10090443
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of collagen gel and hyaluronic acid as vitreous substitutes.
Nakagawa M; Tanaka M; Miyata T
Ophthalmic Res; 1997; 29(6):409-20. PubMed ID: 9380343
[TBL] [Abstract][Full Text] [Related]
17. A new strategy to replace the natural vitreous by a novel capsular artificial vitreous body with pressure-control valve.
Gao Q; Mou S; Ge J; To CH; Hui Y; Liu A; Wang Z; Long C; Tan J
Eye (Lond); 2008 Mar; 22(3):461-8. PubMed ID: 17525767
[TBL] [Abstract][Full Text] [Related]
18. Biocompatibility of polyvinyl alcohol/trisodium trimetaphosphate as vitreous substitute in experimental vitrectomy model in rabbits.
de Oliveira RA; Muralha FP; Grupenmacher AT; de Araújo Morandim-Giannetti A; Bersanetti PA; Maia M; Magalhães Junior O
J Biomed Mater Res B Appl Biomater; 2022 Feb; 110(2):460-466. PubMed ID: 34328263
[TBL] [Abstract][Full Text] [Related]
19. Safety and performance assessment of hyaluronic acid-based vitreous substitutes in patients with phthisis bulbi.
Schulz A; Wakili P; Januschowski K; Heinz WR; Engelhard M; Menz H; Szurman P
Acta Ophthalmol; 2023 Sep; 101(6):687-695. PubMed ID: 36912796
[TBL] [Abstract][Full Text] [Related]
20. Biocompatibility of polyvinylalcohol gel as a vitreous substitute.
Maruoka S; Matsuura T; Kawasaki K; Okamoto M; Yoshiaki H; Kodama M; Sugiyama M; Annaka M
Curr Eye Res; 2006; 31(7-8):599-606. PubMed ID: 16877268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
